FRIDAY, Sept. 19, 2025 (HealthDay News) — Every summer, hazy skies and the smell of burning wood remind Americans that wildfires affect far more than just the communities where they ignite. Their smoke drifts for hundreds, even thousands of miles, darkening the air in cities across the nation. But theContinue Reading
FRIDAY, Sept. 19, 2025 (HealthDay News) — An effective weight-loss pill to rival injectable drugs like Ozempic and Zepbound might be on the horizon, clinical trial results show. An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, according to final clinical trial resultsContinue Reading
THURSDAY, Sept. 18, 2025 (HealthDay News) — Federal health officials want to take Orange B — an artificial food dye that hasn’t been used in more than four decades — off the books. The U.S. Food and Drug Administration (FDA) announced that it plans to repeal regulations that have allowedContinue Reading
WEDNESDAY, Sept. 17, 2025 (HealthDay News) — Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs, including popular weight loss medications. On Tuesday, the U.S. Food and Drug Administration (FDA) released more than 100 warning letters aimed at both drugmakers and online healthContinue Reading
WEDNESDAY, Sept. 17, 2025 (HealthDay News) — LGBTQ+ teenagers in the United States might be losing sleep due to violence, bullying and rejection, a recent study says. Gender and sexual minority teens are more likely to have trouble falling asleep at night, researchers reported in June in the Journal ofContinue Reading
TUESDAY, Sept. 16, 2025 (HealthDay News) — Over-the-counter sales have tanked for the overdose reversal drug naloxone, likely due to its high price, a new study says. Naloxone (Narcan) is a nasal spray that rapidly reverses an overdose by blocking opioid receptors in the body. It has been a keyContinue Reading
TUESDAY, Sept. 16, 2025 (HealthDay News) — A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side effects, new clinical trial results show. Obese folks lost more weight taking 7.2 mg of semaglutide (Ozempic/Wegovy) a week than those taking either theContinue Reading
TUESDAY, Sept. 16, 2025 (HealthDay News) — Most Americans would be healthier if the nation dropped daylight saving time, a major new study says. Switching to permanent standard time would prevent about 300,000 cases of stroke per year and result in 2.6 million fewer people with obesity, researchers estimate inContinue Reading
MONDAY, Sept. 15, 2025 (HealthDay News) — Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new study says. About 52% of people in Denmark prescribed semaglutide (Ozempic, Wegovy) for weight loss stopped taking it after one year, researchers reported Saturday atContinue Reading
SATURDAY, Sept. 13, 2025 (HealthDay News) — On World Sepsis Day, health experts remind Americans that sepsis strikes 1.7 million people in the U.S. each year and causes more than 350,000 deaths. Yet despite those staggering numbers, many Americans don’t know what sepsis is or how to recognize it beforeContinue Reading